Article Details

TG Therapeutics Initiates Rolling Submission of Biologics License Application to US Food and ...

Retrieved on: 2020-12-01 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

TG Therapeutics Initiates Rolling Submission of Biologics License Application to US Food and .... View article details on hiswai:

Excerpt

Ublituximab (TG-1101) is a glycoengineered <b>monoclonal antibody</b> that targets a specific and unique epitope on the CD20 antigen found on mature ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo